News Wire ~ 3rd Party Press Release

186 POSTS 0 COMMENTS
Bilgicer Lab

Researchers Develop First Functional Targeted Inhibitors of Peanut Allergens

“The success of this study is exciting because it opens the door to establishing an entirely new class of allergy therapeutics."
Snap-EMS Kit

Snap Medical Announces EMS-Designed Epinephrine Delivery Kit

Kit can be assembled and ready for administration in 25 seconds.
Infant

AAP Clinical Report Highlights Early Introduction of Peanut-Based Foods to Prevent Allergies

The American Academy of Pediatrics updates a clinical report that explores how maternal and infant nutrition affect development of infant allergies.
Paliforzia (AR101)

US FDA Accepts BLA Filing of Aimmune Therapeutics’ AR101 for Peanut Allergy

If Approved, AR101 Will Be the First Medicine for This Life-Threatening Condition.
Shenna Bellows

State Legislation Would Provide Epinephrine Auto-Injectors at No Cost to Patients

Bill named 'An Act To Save Lives through Epinephrine Autoinjector Accessibility'.
dupilumab

FDA Approves Dupixent® (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents

Therapy targets the IL-4/IL-13 pathway, a key driver of the allergic or type 2 inflammation that underlies atopic dermatitis.
Toothpaste OMIT

Patent Granted for Toothpaste Immunotherapy for Food Allergy

The patent includes claims to the approach of combining allergenic proteins with toothpaste.

AllergyEats Announces 2019 List of Top 10 Most Allergy-Friendly Restaurant Chains in America

Regionally diverse list illustrates growing trend to better accommodate food-allergic diners nationwide.
Eggs

Egg OIT Leads to More Rapid Allergy Desensitization Than Baked-Egg Products

Study suggests oral immunotherapy may lead to higher sustained unresponsiveness to egg for baked-egg tolerant children.